Neurocrine Bioscience buy StockNews.com
Start price
21.06.24
/
50%
€125.00
Target price
21.06.25
-
Performance (%)
-11.16%
End price
22.06.25
€111.05
Summary
This prediction ended on 22.06.25 with a price of €111.05. The prediction for Neurocrine Bioscience disappointed with a performance of -11.16%. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Neurocrine Bioscience | -2.546% | -2.546% | 7.429% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
Comments by StockNews_com for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for NBIX provided by MarketBeat
In the thread Trading Neurocrine Bioscience
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€139.75
04.08.24
04.08.24
-
04.08.25
04.08.25
-21.11%
05.08.25
05.08.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€135.45
27.07.24
27.07.24
-
27.07.25
27.07.25
-16.98%
28.07.25
28.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€134.65
20.07.24
20.07.24
-
20.07.25
20.07.25
-16.26%
21.07.25
21.07.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.85
23.09.23
23.09.23
-
23.09.24
23.09.24
-3.38%
24.09.24
24.09.24